|
|
Osmetech plc was founded in 1993, developing electronic odour sensor ("e-nose") technology. IPO followed in 1994 and in 1999, the Company changed its name from Aromascan to Osmetech refocusing the business on the opportunities within the global healthcare market. With the acquisition of the OPTI (blood gas) product line from Roche Diagnostics in 2003, the Critical Care Diagnostic Division was formed, which more than doubled its level of sales revenues in 3 years through a strong network of international distributors.
|
|
|
|
|
CombiMatrix Corporation is a biotechnology company headquartered near Seattle, Washington, USA, with a subsidiary, CombiMatrix Molecular Diagnostics, headquartered in Irvine, California. CombiMatrix's patented electrochemical manufacturing process utilizes standard semiconductor technology, proprietary software, and chemistry to build arrays of materials -- molecule by molecule. The company's CustomArray products are DNA microarrays, which have uses in pharmaceutical, biotech, and agrochemical industries as well as in research and government markets.
|
|
|
|
|
The Personalized Medicine Coalition (PMC) is an independent, non-profit
group that works to advance the understanding and adoption of
personalized medicine for the ultimate benefit of patients. Our diverse
members
work together to educate opinion leaders and the public about the
issues that will shape how personalized medicine develops - and how
quickly all of us can benefit from it.
|
|
|
